Efficacy and Safety of AUT00063 Versus Placebo in Age-Related Hearing Loss

Completed · Phase 2 · Has a placebo group

Conditions studied: Age-Related Hearing Loss

In brief

This study aims to demonstrate that the investigational drug AUT00063 is effective and safe in the treatment of age-related hearing loss.

Key facts

Study ID

NCT02345031

Run by

Autifony Therapeutics Limited

People needed

78

Starts

2015-01-01

Expected to finish

2016-06-01

Last updated by the study team

2018-08-09

Who can join

Age: 50 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Sacramento ENT — Sacramento, California, United States
• Colorado ENT and Allergy — Colorado Springs, Colorado, United States
• ENT Associates of South Florida — Boca Raton, Florida, United States
• QPS MRA (Miami Research Associates) — Miami, Florida, United States
• University of South Florida — Tampa, Florida, United States
• University of Louisville — Louisville, Kentucky, United States
• Mayo Clinic — Rochester, Minnesota, United States
• The University of Mississippi Medical Center — Jackson, Mississippi, United States
• Long Island Jewish Medical Center — New Hyde Park, New York, United States
• PMG Research Inc. — Wilmington, North Carolina, United States
• Piedmont Ear, Nose, & Throat Associates — Winston-Salem, North Carolina, United States
• Vanderbilt University Medical Center — Nashville, Tennessee, United States
• Jean Brown Research — Murray, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.